R W. Gelling, et.al., Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice., Proceedings of the National Academy of Sciences of the United States of America, 2003, 100

http://rdf.ncbi.nlm.nih.gov/pubmed/12552113

R W. Gelling, et.al., Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice., Proceedings of the National Academy of Sciences of the United States of America, 2003, 100

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Gcgr<tm1Mjch>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3505881

class

http://purl.org/net/cito/citesAsAuthority

• Gcgr<tm1Mjch>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3505881

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased total body fat amount_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0010025I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased brown adipose tissue amount_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0001780I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased circulating leptin level_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0005668I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• prenatal lethality, incomplete penetrance_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0011101I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased circulating glucose level_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0005560I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased litter size_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0001935I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased gonadal fat pad weight_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0009283I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• increased circulating glucagon level_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0002712I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• hypoglycemia_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0000189I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• improved glucose tolerance_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0005292I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased triglyceride level_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0005318I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• increased circulating LDL cholesterol level_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0000182I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• pancreatic islet hyperplasia_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0005491I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• postnatal lethality, incomplete penetrance_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0011086I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• decreased interscapular fat pad weight_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0009295I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch
• increased body mass index_Gcgr<tm1Mjch>/Gcgr<tm1Mjch>
  http://metadb.riken.jp/0006087I129SvC57BL6JSJLGcgrtm1MjchGcgrtm1MjchGcgrtm1Mjch